RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
Oct 9, 2017 – Oct 2, 2026, Dividends reinvested
- Final balance
- $37,782
- CAGR
- +15.95%
- Max drawdown
- −92.10%
- Sharpe ratio
- 0.55
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −11.94%
- 3M
- −18.69%
- 6M
- +7.58%
- YTD
- −13.28%
- 1Y
- −4.53%
- 3Y
- +61.35%
- 5Y
- +47.96%
- Since 2017
- +15.95%
Metrics
Since 2017| Volatility | 69.88% |
|---|---|
| Sortino ratio | 0.88 |
| Calmar ratio | 0.17 |
| Best year, 2022 | +191.78% |
| Worst year, 2021 | −66.43% |
| Positive years | 5 of 8 |
| Longest drawdown | 2.9 years |
Worst drawdowns
Since 2017| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −92.1% | Jan 2021 | May 2022 | Dec 2023 | 2.9 years |
| −63.3% | Jul 2018 | Mar 2020 | Jan 2021 | 2.5 years |
| −47.2% | Jan 2018 | Apr 2018 | Jun 2018 | 4 months |
| −35.5% | Dec 2025 | Mar 2026 | Not yet | 10 months so far |
| −32.5% | Feb 2024 | May 2024 | Jul 2024 | 5 months |
Annual returns
2017 from Oct 9 · 2026 through Oct 2